Timothy A. Chan, Ph.D.
Affiliations: | Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States |
Google:
"Timothy Chan"Parents
Sign in to add mentorRobert E. Steele | research assistant | UC Irvine | ||
Bert Vogelstein | grad student | 2002 | Johns Hopkins (Chemistry Tree) | |
(The p53-dependent G2 checkpoint.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chan TA, Hermeking H, Lengauer C, et al. (2023) Author Correction: 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature |
Sinha N, Sinha S, Valero C, et al. (2022) Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types. Cancer Research |
Samstein RM, Krishna C, Ma X, et al. (2021) Mutations in and differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nature Cancer. 1: 1188-1203 |
Hakimi AA, Attalla K, DiNatale RG, et al. (2020) A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response. Nature Communications. 11: 4168 |
Pitter KL, Casey DL, Lu YC, et al. (2020) Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. Journal of the National Cancer Institute |
Katsoulakis E, Yu Y, Apte AP, et al. (2020) Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncology. 110: 104877 |
Ged Y, Chaim JL, DiNatale RG, et al. (2020) DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. Journal For Immunotherapy of Cancer. 8 |
Wang Y, Wild AT, Turcan S, et al. (2020) Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas. Science Advances. 6: eaaz3221 |
Takahashi H, Kawaguchi T, Yan L, et al. (2020) Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma. Cancers. 12 |
Srivastava RM, Purohit TA, Chan TA. (2020) Diverse Neoantigens and the Development of Cancer Therapies. Seminars in Radiation Oncology. 30: 113-128 |